Aridis Pharmaceuticals, Inc.
ARDSDelisted Sep 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614067
Aridis Pharmaceuticals, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Jun 28, 2024; 18 institutions reported holding it in 13F filings for Q2 2023, worth $392.3K in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding Aridis Pharmaceuticals, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 17 | 20 | +3 |
| Shares | 3.88M | 4.13M | +244.2K (+6.3%) |
| Value | $4.58M | $1.29M | −$3.29M (−71.7%) |
New holders (6)
Institutions that held Aridis Pharmaceuticals, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sabby Management, LLC | 2,140,174 | $672.2K | 2.50% |
| Prudential Financial Inc | 37,600 | $11.8K | 0.00% |
| Acadian Asset Management LLC | 36,533 | $11.0K | 0.00% |
| Susquehanna International Group, LLP | 23,082 | $7.25K | 0.00% |
| HRT Financial LP | 17,227 | $5.00K | 0.00% |
| Jane Street Group, LLC | 15,356 | $4.82K | 0.00% |
Sold out (3)
Institutions that held Aridis Pharmaceuticals, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Armistice Capital, LLC | 2,068,000 | $2.44M |
| Simplex Trading, LLC | 1,719 | $2.00K |
| Bank of America Corp | 40 | $48 |